Real-world associations of cytokine release syndrome and neurotoxicity with efficacy in patients receiving anti-CD-19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: the Mayo Clinic experience

MeSH terms

• Antigens, CD19
• Cell- and Tissue-Based Therapy
• Cytokine Release Syndrome / etiology
• Humans
• Immunotherapy, Adoptive / adverse effects
• Lymphoma, Large B-Cell, Diffuse* / therapy
• Neurotoxicity Syndromes* / diagnosis
• Neurotoxicity Syndromes* / etiology
• Neurotoxicity Syndromes* / therapy
• Receptors, Antigen, T-Cell
• Receptors, Chimeric Antigen* / genetics